Test Price
3,200 AED✅ Home Collection Available
Usher Syndrome NGS & Sanger Testing in UAE | 3200 AED | 2026 DHA Guidelines
تحليل متلازمة آشر الجيني الشامل (الجيل التالي و تأكيد سانغر) في الإمارات | 3200 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (الملخص التنفيذي)
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS + Sanger Workflow.
- Premium Logistics: Paid Hospital‑Grade Home Collection (8 AM–11 PM). ISO‑Certified Cold‑Chain, sample never frozen.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance by a DHA‑licensed specialist to explain your results.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
اختبار جيني متقدم يشمل جميع الجينات المرتبطة بمتلازمة آشر بدقة تشخيصية عالية، مع استشارة طبية بعد النتيجة.
Overview
This test fully sequences all known Usher syndrome genes (MYO7A, USH2A, CDH23, etc.) using Next‑Generation Sequencing with Sanger confirmation, providing the most definitive molecular diagnosis for dual sensory loss. يُغطي التحليل جميع الجينات المعروفة لمتلازمة آشر بدقة 99.9%، مما يتيح التشخيص المبكر وخطط التدخل العلاجي.
| Feature | Our Test | Closest Alternative (Single‑Gene / Static Panels) |
|---|---|---|
| Methodology | NGS (whole coding regions) + orthogonal Sanger confirmation | Limited gene sequencing or PCR‑based; no full‑gene coverage |
| Genes Covered | All known Usher genes (USH1B‑USH3) with deep intronic variants | 1–2 genes; may miss rare types and novel mutations |
| Turnaround Time | 45 working days (complete report with clinical interpretation) | Often 60‑90 working days for equivalent resolution |
| Price | 3200 AED (all‑inclusive) | 2700‑3500 AED (may be for incomplete testing) |
Physician Insight & Safety Protocol
“As an ophthalmologist and geneticist, I understand the emotional weight of a dual sensory loss diagnosis. This test provides the genetic clarity needed to differentiate Usher types, guide cochlear implant candidacy, and initiate visual rehabilitation early. A negative result also brings immense relief and should always be correlated with clinical findings.”
— Dr. Prabhakar Reddy, DHA License 61713011.
Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. Genetic testing does not replace ongoing audiological or ophthalmic care; continue all prescribed therapies unless advised otherwise.
Exclusion Criteria & Urgent Red Flags
- Inability to give informed consent (guardian required for minors under CDS Law 2026).
- Sample showing frank hemolysis or freeze‑thaw damage (recollection mandated).
- Recent blood transfusion (within 2 weeks) may cause donor DNA interference; please inform the lab.
- Red Flag: If you experience acute sudden hearing loss or vision blackouts, go to the ER immediately; this test is not for acute emergencies.
Frequently Asked Questions
1. What is Usher syndrome and how does this test confirm it?
Usher syndrome is a genetic disorder causing progressive vision loss (retinitis pigmentosa) and hearing impairment, confirmed by NGS analysis of all 11+ causative genes, validated by Sanger sequencing for any detected variant. The test reads every exon of genes like MYO7A, USH2A, and GPR98, identifying pathogenic mutations that explain your child’s or your own combined sensory deficits. متلازمة آشر هي اضطراب وراثي يسبب فقدان السمع والبصر التدريجي، ويؤكدها التحليل الجيني الشامل بالجيل التالي مع تأكيد سانغر.
2. Why choose this over a single‑gene or hearing loss panel?
Our comprehensive NGS panel reads all Usher genes simultaneously with deep coverage, eliminating the risk of missing dual‑symptom variants that single‑gene or incomplete panels might overlook. Unlike limited panels, we provide full interpretation according to ACMG 2026 guidelines, linking genotype to exact Usher clinical subtype. يقرأ لوحنا الجيني جميع جينات آشر مرة واحدة بعمق عالي، مما يضمن عدم تفويت الطفرات النادرة ويربط النمط الجيني بالتصنيف السريري الدقيق.
3. What sample is needed and how should it be prepared?
Collect 10 mL whole blood in two Lavender Top (EDTA) tubes; ship refrigerated (do NOT freeze) and attach a completed Whole Exome Sequencing Consent Form (Form 37) mandatory. Our mobile phlebotomist handles collection and cold‑chain transport, so you only need to sign the consent. اسحب 10 مل من الدم الوريدي في أنبوبين بنفسجيين (EDTA)، واحفظها مبردة دون تجميد، مع نموذج الموافقة الإلزامي (Form 37).
UAE Regulatory Compliance & Quality
- Licensed by DHA/MOHAP – Facility License No. 9834453.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
- Testing complies with Federal Decree-Law No. (41) of 2024 on Medical Liability (Art. 87), the UAE PDPL for genetic data protection, and the CDS Law 2026 for minor consent.
- All genetic data is processed within UAE‑sovereign servers under strict encryption.
For home collection booking and insurance verification, contact +971 54 548 8731 (8 AM–11 PM) or WhatsApp.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians